Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Cash from Operations (2015 - 2025)

Updated

Adaptimmune Therapeutics (ADAPY) posted Cash from Operations of -$34.8 million for Q2 2025, compared with $47.4 million a year earlier.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Cash from Operations (2015 - 2025) Analysis & Trends

For the trailing twelve months through Jun 30, 2025, Cash from Operations at Adaptimmune Therapeutics was -$190.06 million; for FY2024, it was -$73.21 million.

  • In prior years, Adaptimmune Therapeutics' Cash from Operations was -$140.88 million in FY2023, -$141.77 million in FY2022, $10.73 million in FY2021 and -$53.59 million in FY2020.
  • Quarterly Cash from Operations has run from a low of -$66.6 million in Q1 2025 to a high of $133.93 million in Q4 2021 over five years.
  • According to Business Quant data, Cash from Operations for the three prior quarters was -$66.6 million (Q1 2025), -$34.2 million (Q4 2024) and -$54.45 million (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -34.80 Mn
Mar 31, 2025 -66.60 Mn
Dec 31, 2024 -34.20 Mn
Sep 30, 2024 -54.45 Mn
Jun 30, 2024 47.40 Mn
Mar 31, 2024 -31.95 Mn
Dec 31, 2023 -14.68 Mn
Sep 30, 2023 -45.16 Mn
Jun 30, 2023 -43.76 Mn
Mar 31, 2023 -37.28 Mn
Dec 31, 2022 2.04 Mn
Sep 30, 2022 -48.16 Mn
Jun 30, 2022 -41.25 Mn
Mar 31, 2022 -54.40 Mn
Dec 31, 2021 133.93 Mn
Sep 30, 2021 -45.20 Mn
Jun 30, 2021 -31.46 Mn
Mar 31, 2021 -46.54 Mn
Dec 31, 2020 -29.22 Mn
Sep 30, 2020 -16.32 Mn
API Access

Adaptimmune Therapeutics PLC Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ADAPY&period=max&api_key=YOUR_API_KEY